← Back to Search

Fasted Exercise for Type 2 Diabetes (FED Trial)

N/A
Waitlist Available
Led By Normand Boulé, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Physician diagnosed type 2 diabetes
Treated with diet and/or glucose lowering medications, but not insulin, for at least 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from the first two to the last two weeks of the 16 week interventions
Awards & highlights

FED Trial Summary

This trial will compare the effects of exercising in the morning before breakfast to exercising after breakfast in people with type 2 diabetes.

Eligible Conditions
  • Type 2 Diabetes

FED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

FED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from the first two to the last two weeks of the 16 week interventions
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from the first two to the last two weeks of the 16 week interventions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentration of HbA1c (mmol/mol)
Liver fat (%)
Secondary outcome measures
Aerobic fitness
Body weight (kilograms)
Concentrations of Fasting glucose
+9 more

FED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Fasted ExerciseExperimental Treatment1 Intervention
Exercise training will be performed in the fasted state (i.e., before breakfast).
Group II: Postprandial ExerciseActive Control1 Intervention
Exercise will be performed in the postprandial period (i.e., after breakfast)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fasted Exercise
2019
N/A
~40

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
883 Previous Clinical Trials
393,189 Total Patients Enrolled
Normand Boulé, PhDPrincipal InvestigatorUniversity of Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025